Oblimersen combined with docetaxel, adriamycin and cyclophosphamide as neo-adjuvant systemic treatment in primary breast cancer: final results of a multicentric phase I study.

Rom, J; von Minckwitz, G; Eiermann, W; Sievert, M; Schlehe, B; Marmé, F; Schuetz, F; Scharf, A; Eichbaum, M; Sinn, H-P; Kaufmann, M; Sohn, C; Schneeweiss, A

Rom, J; von Minckwitz, G; Eiermann, W; Sievert, M; Schlehe, B; Marmé, F; Schuetz, F; Scharf, A; Eichbaum, M; Sinn, H-P; Kaufmann, M; Sohn, C; Schneeweiss, A.

Affiliation

Rom J; Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany. joachim.rom@med.uni-heidelberg.de

Ann Oncol ; 19(10): 1698-705, 2008 Oct.

Article in En | MEDLINE | ID: mdl-18477581

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/adverse effects; Breast Neoplasms/drug therapy; Carcinoma, Ductal, Breast/drug therapy; Adult; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/blood; Carcinoma, Ductal, Breast/blood; Cyclophosphamide/administration & dosage; Cyclophosphamide/adverse effects; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin/administration & dosage; Doxorubicin/adverse effects; Female; Humans; Middle Aged; Neoadjuvant Therapy; Taxoids/administration & dosage; Taxoids/adverse effects; Thionucleotides/administration & dosage; Thionucleotides/adverse effects; Thionucleotides/pharmacokinetics

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Ductal, Breast Type of study: Clinical_trials Limits: Adult / Female / Humans / Middle aged Language: En Journal: Ann Oncol Year: 2008 Document type: Article

Fulltext

XML

PubMed Links

Search on Google